Patent details

EP2943224 Title: VORICONAZOLE INCLUSION COMPLEXES

Basic Information

Publication number:
EP2943224
PCT Application Number:
EP2014050328
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147001937
PCT Publication Number:
WO2014108474
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
VORICONAZOLE INCLUSION COMPLEXES
French Title of Invention:
COMPLEXES D'INCLUSION DE VORICONAZOLE
German Title of Invention:
VORICONAZOL INKLUSIONSKOMPLEXE
SPC Number:

Dates

Filing date:
09/01/2014
Grant date:
01/01/2020
EP Publication Date:
18/11/2015
PCT Publication Date:
17/07/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/01/2020
EP B1 Publication Date:
01/01/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/01/2020
Expiration date:
09/01/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/12/2019
 
 

Name:
Xellia Pharmaceuticals ApS
Address:
Dalslandsgade 11, 2300 Copenhagen S, Denmark (DK)

Inventor

1

Name:
JASPRICA, Ivona
Address:
Croatia (HR)

2

Name:
BEVETEK MOCNIK, Anita
Address:
Croatia (HR)

3

Name:
GRUBESIC, Sasa
Address:
Croatia (HR)

Priority

Priority Number:
201361751394 P
Priority Date:
11/01/2013
Priority Country:
United States (US)

Classification

IPC classification:
B82Y 5/00; A61P 31/10; C08B 37/16; A61K 47/69;

Publication

European Patent Bulletin

Issue number:
202001
Publication date:
01/01/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages